Tech Tuesday: Neobiosis
We talk with Dr. Ian White of Neobiosis, a biotech company with a passion around regenerative medicine. With the tagline "Regenerative Science", they're commitment to finding innovative solutions for a multitude of fields.
Pheronym Lands $1 Million National Science Foundation Sbir Phase II Grant
UF Innovate | Accelerate alum, Pheronym, an ag-biotech pest management company, has been awarded a second non-dilutive National Science Foundation (NSF) SBIR Phase II for $1 Million. The grant will fund the final steps to scaling commercial manufacturing of their sustainable, eco-, and climate-friendly approach to pest control. The target pests include Thrips, a globally important pest that developed resistance to chemical pesticides.
Hack #9| Entrepreneurship is Boundaryless
#9 Hack of The Week emphasizes the importance of collaboration, global networking, and embracing the entrepreneurial ecosystem to foster innovation and resilience. It highlights real-world examples, such as the rental umbrella service in Tokyo and the airport operations industry's successful recovery after the COVID-19 pandemic.
Positive Results in Cancer Vaccine Trial for Merkel Cell Carcinoma and Cutaneous Squamous Cell Carcinoma
Morphogenesis, Inc., a biotechnology company focused on developing cancer vaccines, in partnership with CohBar, believes they have met their milestone with IFx-HU2.0, a cancer vaccine studied in advanced Merkel cell carcinoma and squamous cell carcinoma.
Neobiosis Announces FDA Approval of IND for Use of ViXomeTM in COVID-19 ‘Post COVID Syndrome’
Neobiosis, A UF Accelerate resident client, is a leading research and manufacturing biotechnology company focused on pioneering the development of novel therapeutics from perinatal tissues as a new class of medicines. Today, Neobiosis announced that the U.S. Food and Drug Administration (FDA) has approved the Investigational New Drug (IND) application for ViXome™, its drug for the treatment of 'Post COVID Syndrome (AKA "Long Haul COVID Syndrome").
Tech Tuesday: Oneness Technologies
In this week's Tech Tuesday featured on WCJB TV20, we interview Dr. Neha Chavan and Alex Blanton from Oneness Technologies, a biotech company that combines cutting-edge scientific expertise with a plant-based medicine approach. The startup's technology revolutionizes the health and wellness industry by ensuring maximum absorption of hemp products in the body, minimizing wastage, and reducing side effects.
UF Startups Among Companies Selected for U.S. Funding to Reduce Carbon Emissions
UF startup Micro Nano Technologies, incubating at UF Innovate | Accelerate at The Hub, is one of six companies sharing $16.2 million in funding for decarbonizing paper and forest products. The goal is to reduce net energy GHG emissions in the paper and forest products industry including increasing the share of renewable energy used, electrification, carbon capture, and energy efficiency.
EU Adds 9 Startups to Contribute Data to Copernicus Mission
The European Union (EU) has added nine startups -- including Spain-based Satlantis, the parent company of UF startup Satlantis LLC -- to contribute data to the Copernicus project. Each startup will receive a 5 million euro contract to provide additional data to Copernicus.
Tech Tuesday: Fire Neural Network
In this week’s Tech Tuesday, we interview
Dr. Istvan Kereszy, CEO of Fire Neural Network (FNN), to explore their groundbreaking work in lighting detection and its crucial role in preventing wildfires. Hear how their advanced technological detectors can identify high-risk strikes and are helping mitigate fires.
Dmitry Rinberg on the Mysteries of Smell
"Don't miss this fascinating interview with Dmitry Rinberg, Co-founder and Chief Science Advisor of Canaery, a resident of UF Innovate | Accelerate, as he explores the mysteries of smell with Vasant Dhar. Join AI-pioneer Vasant Dhar as he hosts 'Brave New World' and discover the transformation of humanity by machines in the post-COVID era. The conversation will touch on various topics such as work, health, faith, emotional well-being, government, democracy, and freedom."
